טוען...
How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?
OBJECTIVE: The optimal treatment strategy for pathologic single-station N2 (pN2a1) non-small cell lung cancer (NSCLC)—surgery first followed by adjuvant treatment (SF) or neoadjuvant therapy followed by surgery (NS)—remains unclear. We compared disease-free survival (DFS) and overall survival (OS) a...
שמור ב:
| הוצא לאור ב: | Semin Thorac Cardiovasc Surg |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904958/ https://ncbi.nlm.nih.gov/pubmed/32853736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semtcvs.2020.08.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|